Details for Patent: 10,022,510
✉ Email this page to a colleague
Which drugs does patent 10,022,510 protect, and when does it expire?
Patent 10,022,510 protects QVAR 40, QVAR 80, and QVAR REDIHALER, and is included in two NDAs.
This patent has one hundred and ninety-two patent family members in twenty-four countries.
Summary for Patent: 10,022,510
| Title: | Dose counters for inhalers, inhalers and methods of assembly thereof |
| Abstract: | A tape system for a dose counter for an inhaler, the tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the tape, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and one end of the tape. |
| Inventor(s): | Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg |
| Assignee: | Teva Pharmaceuticals Ireland , Ivax Pharmaceuticals Ireland , Norton Waterford Ltd , Nypro Inc |
| Application Number: | US15/271,738 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,022,510 |
|
Patent Claim Types: see list of patent claims | Delivery; |
Drugs Protected by US Patent 10,022,510
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | QVAR 40 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-002 | Sep 15, 2000 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Norton Waterford | QVAR REDIHALER | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 207921-001 | Aug 3, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,022,510
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011254958 | ⤷ Start Trial | |||
| Brazil | 112012029106 | ⤷ Start Trial | |||
| Canada | 2799625 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
